Breaking News: Embargoed Feed - hidden

Filters close
Newswise:Video Embedded carbohydrate-polymers-could-be-a-sweet-solution-for-water-purification
VIDEO
6-Sep-2024 8:00 AM EDT
Carbohydrate polymers could be a sweet solution for water purification
American Chemical Society (ACS)

Researchers in ACS Central Science report a sugar-like polymer that traps heavy metals within insoluble clumps for easy removal. In proof-of-concept tests, the polymer removed ionic cadmium and lead from river water spiked with these persistent contaminants.

Query Closed
Reporter's Deadline Passed
6-Sep-2024 6:46 AM EDT
I am trying to find - Liz Scherer, Independent
Newswise Expert Queries

I am trying to find a primary care physician who can discuss generational differences amongst

Query Closed
Reporter's Deadline Passed
4-Sep-2024 4:32 PM EDT
Hi. I am seeking a - Liz Scherer, Independent
Newswise Expert Queries

Hi. I am seeking a primary care doctor whose practice has a lot of men

Newswise: First Neutrinos Detected at Fermilab Short-Baseline Detector
10-Sep-2024 10:00 AM EDT
First Neutrinos Detected at Fermilab Short-Baseline Detector
Fermi National Accelerator Laboratory (Fermilab)

After years of preparation, the first neutrinos have been observed by the Short-Baseline Near Detector collaboration. The data SBND collects will expand our knowledge of how neutrinos interact with matter and will be used to search for evidence of new physics.

10-Sep-2024 8:00 AM EDT
Scientists Turn On Powerful New Machine for Study of Fundamental Physics
Rutgers University-New Brunswick

After nearly a decade of preparation, scientists – including researchers from Rutgers University – have turned on a new apparatus capable of detecting a host of mysterious tiny particles. Researchers working on the Short-Baseline Near Detector (SBND) at Fermi National Accelerator Laboratory (Fermilab) in Batavia, Ill., have started up the new machine and begun detecting the neutrinos produced by Fermilab’s particle accelerator beams.

Not for public release

This news release is embargoed until 10-Sep-2024 2:00 PM EDT Released to reporters: 10-Sep-2024 7:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 10-Sep-2024 2:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

6-Sep-2024 2:05 PM EDT
New Law Regulating Out-of-Pocket Drug Spending Saves Cancer Patients More Than $7,000 a Year, Study Finds
Michigan Medicine - University of Michigan

As prescription oral chemotherapies have become a common form of cancer treatment, some patients were paying more than $10,000 a year for medications. A new study finds that efforts to cap prescription drug spending are yielding significant out-of-pocket savings for these patients.

Newswise: Mark Awad Named Chief of the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center
9-Sep-2024 5:00 PM EDT
Mark Awad Named Chief of the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center

Mark Awad, MD, PhD, has been appointed Chief of the Thoracic Oncology Service within the Solid Tumor Oncology Division, Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK).

Newswise: UC San Diego Receives $10 Million for Center on Neurobiology in Changing Environments
9-Sep-2024 3:05 PM EDT
UC San Diego Receives $10 Million for Center on Neurobiology in Changing Environments
University of California San Diego

The Paul G. Allen Frontiers Group has selected UC San Diego’s Scripps Institution of Oceanography to receive a four-year, $10 million grant funded by the Paul G. Allen Family Foundation to establish the Allen Discovery Center for Neurobiology in Changing Environments. The center will take a multidisciplinary approach to investigating how climate change may impact the nervous systems and behavior of marine animals.

Not for public release

This news release is embargoed until 9-Sep-2024 5:00 PM EDT Released to reporters: 3-Sep-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 9-Sep-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 9-Sep-2024 5:00 PM EDT Released to reporters: 3-Sep-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 9-Sep-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

5-Sep-2024 10:05 AM EDT
FASEB Selects Howard Garrison Advocacy Fellows
Federation of American Societies for Experimental Biology (FASEB)

The Federation of American Societies for Experimental Biology (FASEB) selected nine scientists as the 2024 Howard Garrison Advocacy Fellows.

6-Sep-2024 3:05 PM EDT
A Gun Safety Paradox: Study Finds Some Precautions Linked to Riskier Storage Practices
Rutgers University-New Brunswick

Rutgers Health researchers surveyed 870 parents in nine states with diverse firearm policies and ownership rates.

9-Sep-2024 9:05 AM EDT
Unveiling the Math Behind Your Calendar
Case Western Reserve University

In a world where organizing a simple meeting can feel like herding cats, new research from Case Western Reserve University reveals just how challenging finding a suitable meeting time becomes as the number of participants grows.

Newswise: Researchers Identify Factor That Drives Prostate Cancer-Causing Genes
5-Sep-2024 4:05 PM EDT
Researchers Identify Factor That Drives Prostate Cancer-Causing Genes
Michigan Medicine - University of Michigan

Researchers at the University of Michigan Health Rogel Cancer Center have uncovered a key reason why a typically normal protein goes awry and fuels cancer. They found the protein NSD2 alters the function of the androgen receptor, an important regulator of normal prostate development.

Newswise: Immunotherapy Before and After Lung Cancer Surgery Reduces Death Risk, Disease Recurrence
5-Sep-2024 10:00 AM EDT
Immunotherapy Before and After Lung Cancer Surgery Reduces Death Risk, Disease Recurrence
Johns Hopkins Medicine

People with operable non-small cell lung cancers may fare better over the next few years by receiving immunotherapy treatments before and after surgery instead of only before surgery, according to a new analysis by Johns Hopkins Kimmel Cancer Center investigators.

Newswise: Age-Related Changes in Male Fibroblasts Increase Treatment-Resistant Melanoma
4-Sep-2024 10:00 AM EDT
Age-Related Changes in Male Fibroblasts Increase Treatment-Resistant Melanoma
Johns Hopkins Medicine

Age-related changes in the fibroblasts, cells that create the skin’s structure, contribute to the development of aggressive, treatment-resistant melanoma in males, according to research in mice by the Johns Hopkins Kimmel Cancer Center.

Query Closed
Reporter's Deadline Passed
3-Sep-2024 5:00 PM EDT
I'm writing an overview - Gail Dutton, BioSpace
Newswise Expert Queries

I'm writing an overview of the anti-TIGIT cancer therapeutic space. What's behind

Newswise: Global experts help nanomedicines DELIVER on healthcare promise
5-Sep-2024 12:05 AM EDT
Global experts help nanomedicines DELIVER on healthcare promise
University of South Australia

New findings from a global team of expert scientists in academia and industry has generated world-first research quality standards that will help slash costs and reduce the time it takes to develop advanced nanomedicine treatments and make them available for patients.

5-Sep-2024 3:35 PM EDT
100x Improvement in Sight Seen After Gene Therapy Trial
Perelman School of Medicine at the University of Pennsylvania

The vision of people with a rare inherited condition that causes them to lose much of their sight early in childhood was 100 times better after they received gene therapy to address the genetic mutation causing it. Some patients even experienced a 10,000-fold improvement in their vision after receiving the highest dose of the therapy, according to researchers from the Perelman School of Medicine at the University of Pennsylvania who co-led the clinical trial published in The Lancet.



close
7.84987